Check Cap (NASDAQ:CHEK) released its earnings results on Monday. The medical research company reported ($0.44) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.47) by $0.03, MarketWatch Earnings reports.
Check Cap stock opened at $2.19 on Wednesday. Check Cap has a 52 week low of $1.62 and a 52 week high of $5.43.
CHEK has been the subject of several research analyst reports. Dougherty & Co initiated coverage on Check Cap in a research note on Tuesday, February 5th. They set a “buy” rating and a $6.00 target price for the company. Zacks Investment Research upgraded Check Cap from a “hold” rating to a “buy” rating and set a $2.25 target price for the company in a research note on Monday, March 4th.
COPYRIGHT VIOLATION WARNING: “Check Cap (CHEK) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS” was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://www.baseballdailydigest.com/news/2019/05/15/check-cap-chek-posts-quarterly-earnings-results-beats-estimates-by-0-03-eps.html.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit worn on the patient's back for capsule control, tracking, and data recording; and C-Scan View, a personal computer-based software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface.
Featured Article: Why Invest in Dividend Achievers?
Receive News & Ratings for Check Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap and related companies with MarketBeat.com's FREE daily email newsletter.